BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9376605)

  • 1. Full immunologic reconstitution following nonconditioned bone marrow transplantation for canine X-linked severe combined immunodeficiency.
    Felsburg PJ; Somberg RL; Hartnett BJ; Suter SF; Henthorn PS; Moore PF; Weinberg KI; Ochs HD
    Blood; 1997 Oct; 90(8):3214-21. PubMed ID: 9376605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplantation of X-linked severe combined immunodeficient dogs with CD34+ bone marrow cells.
    Hartnett BJ; Yao D; Suter SE; Ellinwood NM; Henthorn PS; Moore PE; McSweeney PA; Nash RA; Brown JD; Weinberg KI; Felsburg PJ
    Biol Blood Marrow Transplant; 2002; 8(4):188-97. PubMed ID: 12014808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow transplantation for canine X-linked severe combined immunodeficiency.
    Hartnett BJ; Henthorn PS; Moore PF; Weinberg KI; Ochs HD; Felsburg PJ
    Vet Immunol Immunopathol; 1999 Aug; 69(2-4):137-44. PubMed ID: 10507301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe papillomavirus infection progressing to metastatic squamous cell carcinoma in bone marrow-transplanted X-linked SCID dogs.
    Goldschmidt MH; Kennedy JS; Kennedy DR; Yuan H; Holt DE; Casal ML; Traas AM; Mauldin EA; Moore PF; Henthorn PS; Hartnett BJ; Weinberg KI; Schlegel R; Felsburg PJ
    J Virol; 2006 Jul; 80(13):6621-8. PubMed ID: 16775349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canine X-linked severe combined immunodeficiency.
    Felsburg PJ; Hartnett BJ; Henthorn PS; Moore PF; Krakowka S; Ochs HD
    Vet Immunol Immunopathol; 1999 Aug; 69(2-4):127-35. PubMed ID: 10507300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell repertoire development in XSCID dogs following nonconditioned allogeneic bone marrow transplantation.
    Vernau W; Hartnett BJ; Kennedy DR; Moore PF; Henthorn PS; Weinberg KI; Felsburg PJ
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1005-15. PubMed ID: 17697962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-cell function in canine X-linked severe combined immunodeficiency.
    Hartnett BJ; Somberg RL; Krakowka S; Ochs HD; HogenEsch H; Moore PF; Weinberg KI; Felsburg PJ
    Vet Immunol Immunopathol; 2000 Jun; 75(1-2):121-34. PubMed ID: 10889304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postnatal development of T cells in dogs with X-linked severe combined immunodeficiency.
    Somberg RL; Tipold A; Hartnett BJ; Moore PF; Henthorn PS; Felsburg PJ
    J Immunol; 1996 Feb; 156(4):1431-5. PubMed ID: 8568244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retroviral transduction of IL2RG into CD34(+) cells from X-linked severe combined immunodeficiency patients permits human T- and B-cell development in sheep chimeras.
    Tsai EJ; Malech HL; Kirby MR; Hsu AP; Seidel NE; Porada CD; Zanjani ED; Bodine DM; Puck JM
    Blood; 2002 Jul; 100(1):72-9. PubMed ID: 12070011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ex vivo culture of CD34+ bone marrow cells on immune reconstitution of XSCID dogs following allogeneic bone marrow transplantation.
    Kennedy DR; McLellan K; Moore PF; Henthorn PS; Felsburg PJ
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):662-70. PubMed ID: 19450750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo competitive studies between normal and common gamma chain-defective bone marrow cells: implications for gene therapy.
    Otsu M; Sugamura K; Candotti F
    Hum Gene Ther; 2000 Sep; 11(14):2051-6. PubMed ID: 11020803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canine X-linked severe combined immunodeficiency. A model for investigating the requirement for the common gamma chain (gamma c) in human lymphocyte development and function.
    Felsburg PJ; Somberg RL; Hartnett BJ; Henthorn PS; Carding SR
    Immunol Res; 1998; 17(1-2):63-73. PubMed ID: 9479568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction of canine X-linked severe combined immunodeficiency by in vivo retroviral gene therapy.
    Ting-De Ravin SS; Kennedy DR; Naumann N; Kennedy JS; Choi U; Hartnett BJ; Linton GF; Whiting-Theobald NL; Moore PF; Vernau W; Malech HL; Felsburg PJ
    Blood; 2006 Apr; 107(8):3091-7. PubMed ID: 16384923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal bone marrow transplantation of ADA-deficient SCID mice results in immunologic reconstitution despite low levels of engraftment and an absence of selective donor T lymphoid expansion.
    Carbonaro DA; Jin X; Cotoi D; Mi T; Yu XJ; Skelton DC; Dorey F; Kellems RE; Blackburn MR; Kohn DB
    Blood; 2008 Jun; 111(12):5745-54. PubMed ID: 18356486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T lymphocyte development and function in dogs with X-linked severe combined immunodeficiency.
    Somberg RL; Robinson JP; Felsburg PJ
    J Immunol; 1994 Nov; 153(9):4006-15. PubMed ID: 7930609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between patterns of engraftment in peripheral blood and immune reconstitution after allogeneic bone marrow transplantation for (severe) combined immunodeficiency.
    van Leeuwen JE; van Tol MJ; Joosten AM; Schellekens PT; van den Bergh RL; Waaijer JL; Oudeman-Gruber NJ; van der Weijden-Ragas CP; Roos MT; Gerritsen EJ
    Blood; 1994 Dec; 84(11):3936-47. PubMed ID: 7949150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retroviral marking of canine bone marrow: long-term, high-level expression of human interleukin-2 receptor common gamma chain in canine lymphocytes.
    Whitwam T; Haskins ME; Henthorn PS; Kraszewski JN; Kleiman SE; Seidel NE; Bodine DM; Puck JM
    Blood; 1998 Sep; 92(5):1565-75. PubMed ID: 9716584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced memory B-cell populations in boys with B-cell dysfunction after bone marrow transplantation for X-linked severe combined immunodeficiency.
    Ting SS; Tangye SG; Wood J; Ffrench RA; Ziegler JB
    Br J Haematol; 2001 Mar; 112(4):1004-11. PubMed ID: 11298599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients.
    Haddad E; Landais P; Friedrich W; Gerritsen B; Cavazzana-Calvo M; Morgan G; Bertrand Y; Fasth A; Porta F; Cant A; Espanol T; Müller S; Veys P; Vossen J; Fischer A
    Blood; 1998 May; 91(10):3646-53. PubMed ID: 9573000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of reduced intensity conditioning in T-cell and B-cell immune reconstitution after HLA-identical bone marrow transplantation in ADA-SCID.
    Cancrini C; Ferrua F; Scarselli A; Brigida I; Romiti ML; Barera G; Finocchi A; Roncarolo MG; Caniglia M; Aiuti A
    Haematologica; 2010 Oct; 95(10):1778-82. PubMed ID: 20460637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.